Orthopedics

Your Article Summary

See Latest Articles

Analysing uncertainty around costs of innovative medical technologies: The case of fibrin sealant (QUIXIL®) for total knee replacement
Health Policy, 09/02/08

Steuten L et al. - Whether using fibrin sealant is cost saving strongly depends on the amount used, the achieved reduction in hospital length of stay (LOS) and price of QUIXIL®. If a 10-ml dose of fibrin sealant is required to achieve the effects as described in the published trials, its use adds cost, but if 25% or more of patients are treated with a 5-ml dose, its use becomes cost saving for the NHS.

Today in Knee...keeping you current

Receive free subspecialty "5-minute updates" via email

Elevated Circulating and Synovial Fluid Endoglin Are Associated with Primary Knee Osteoarthritis Severity
Archives of Medical Research, 12/17/09

Dosimetry during intramedullary nailing of the tibia
Acta Orthopaedica, 12/17/09

Nonunions around the knee joint
International Orthopaedics, 12/17/09

 See all of Knee

Today in New Products...keeping you current

Receive free subspecialty "5-minute updates" via email

A Novel Patient-Specific Navigational Template for Cervical Pedicle Screw Placement
Spine, 12/17/09

The new dual osteotomy: combined open wedge and tibial tuberosity anteriorisation osteotomies
International Orthopaedics, 12/14/09

Treatment of Displaced Proximal Fifth Metatarsal Fractures Using a New One-Step Fixation Technique
Journal of Trauma, 12/14/09

 See all of New Products